ALMR earnings: next report 2026-08-10, real EPS beat/miss history, P/E -55.82. Updated 2026-07-23.
Alamar Biosciences (ALMR) Research Hub
Alamar Biosciences (ALMR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 27.89 USD (-3.69%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -55.82, market cap 0.24B. This hub links to the full technical, earnings and options research available for ALMR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 27.89 USD (-3.69%) |
| 52-week range | 19.81 USD – 38.54 USD |
| Trend regime | Range |
| 14-day RSI | 49 (Neutral) |
| Trailing P/E | -55.82 |
| Market cap | 0.24B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for ALMR
Covered Call on ALMR: how it works, illustrative setup around the real 27.89 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ALMR: how it works, illustrative setup around the real 27.89 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ALMR: how it works, illustrative setup around the real 27.89 USD price, max profit/loss, breakeven and when to use it. Educational.
ALMR technical analysis: range, last 27.89 USD, RSI 49, 52w range 19.81 USD–38.54 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ALMR in?
Alamar Biosciences (ALMR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ALMR in an uptrend or downtrend?
As of 2026-09-11, ALMR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ALMR's trailing P/E ratio?
ALMR's trailing P/E is -55.82, with a market cap of 0.24B. See the earnings research page for full valuation detail.
When does ALMR next report earnings?
ALMR is next scheduled to report earnings on 2026-08-10, with a consensus EPS estimate of -0.36 USD.